Education
About Us
Working with TipRanks
Follow Us
ReShape Lifesciences (RSLS)
NASDAQ:RSLS
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 8.01M | $ 8.68M | $ 11.24M | $ 13.60M | $ 11.30M |
| Gross Profit | $ 5.06M | $ 5.55M | $ 6.80M | $ 8.35M | $ 6.26M |
| Operating Income | $ -6.67M | $ -14.64M | $ -27.08M | $ -27.75M | $ -12.46M |
| EBITDA | $ -6.67M | $ -14.48M | $ -24.93M | $ -60.62M | $ -18.09M |
| Net Income | $ -7.13M | $ -11.39M | $ -46.21M | $ -61.93M | $ -21.63M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 693.00K | $ 4.46M | $ 3.85M | $ 22.77M | $ 2.96M |
| Total Assets | $ 4.79M | $ 10.66M | $ 11.14M | $ 54.26M | $ 37.06M |
| Total Debt | $ 967.00K | $ 262.00K | $ 171.00K | $ 279.00K | $ 477.00K |
| Net Debt | $ 274.00K | $ -4.20M | $ -3.68M | $ -22.49M | $ -2.48M |
| Total Liabilities | $ 5.05M | $ 4.00M | $ 7.48M | $ 8.19M | $ 22.57M |
| Stockholders' Equity | $ -253.00K | $ 6.66M | $ 3.66M | $ 46.07M | $ 14.49M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.43M | $ -17.00M | $ -22.03M | $ -15.73M | $ -8.94M |
| Operating Cash Flow | $ -4.43M | $ -16.96M | $ -21.90M | $ -15.38M | $ -8.55M |
| Investing Cash Flow | $ 0.00 | $ -10.00K | $ -92.00K | $ 1.85M | $ -2.39M |
| Financing Cash Flow | $ 677.00K | $ 17.57M | $ 3.13M | $ 33.30M | $ 11.07M |